Breaking News
Related Searches:
3511 - 3525 of 6714 results
Prev
233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448
Next
March 25, 2010
Michael Curry has been named director of Sterile Operations at DPT Laboratories’ Center of Excellence for Sterile & Specialty Products, in Lakewood, NJ.
Read More »
March 25, 2010
Dainippon Sumitomo Pharma America, Inc.’s NDA for lurasidone for the treatment of acute schizophrenia has been accepted for review by the FDA.
Read More »
March 24, 2010
PPD, Inc. is launching the Vaccines & Biologics Center of Excellence, a network of integrated lab services focused on vaccine and biologic drug development.
Read More »
March 24, 2010
Lois Johnson has been appointed vice president of Quality, Development and Clinical Services, and Alex Eslava has been named vice president of Quality, Sterile Technologies, at Catalent Pharma Solutions.
Read More »
March 23, 2010
Merck Serono has temporarily suspended the worldwide clinical development program for Stimuvax (BLP25 liposomal vaccine) due to an unexpected serious adverse reaction in a patient with multiple myeloma.
Read More »
March 22, 2010
Geoff Owen has been named senior vice president, global business development, for Quintiles’ Commercial business.
Read More »
March 22, 2010
Cellceutix Corp. has concluded an agreement with Formatech, Inc. to formulate Kevetrin for a Phase I study.
Read More »
March 22, 2010
Nicholas A. LaBella Jr., MS, RPh, has joined Insmed as chief scientific officer, a newly-created position on the executive team.
Read More »
3511 - 3525 of 6714 results
Prev
233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448
Next
